Last reviewed · How we verify
chiglitazar sodium tablets
At a glance
| Generic name | chiglitazar sodium tablets |
|---|---|
| Also known as | Bilessglu®, CS-038, Carfloglitazar |
| Sponsor | Chipscreen Biosciences, Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase II Clinical Trial of Chiglitazar for NASH (PHASE2)
- Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |